TAO-kinase 3 governs the terminal differentiation of NOTCH2-dependent splenic conventional dendritic cells.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 33214146.
- Also identified by DOI 10.1073/pnas.2009847117 and PMC identifier 7733863.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Antigen-presenting conventional dendritic cells (cDCs) are broadly divided into type 1 and type 2 subsets that further adapt their phenotype and function to perform specialized tasks in the immune system. The precise signals controlling tissue-specific adaptation and differentiation of cDCs are currently poorly understood. We found that mice deficient in the Ste20 kinase Thousand and One Kinase 3 (TAOK3) lacked terminally differentiated ESAM<sup>+</sup> CD4<sup>+</sup> cDC2s in the spleen and failed to prime CD4<sup>+</sup> T cells in response to allogeneic red-blood-cell transfusion. These NOTCH2- and ADAM10-dependent cDC2s were absent selectively in the spleen, but not in the intestine of <i>Taok3</i><sup>-/-</sup> and <i>CD11c-cre Taok3</i><sup>fl/fl</sup> mice. The loss of splenic ESAM<sup>+</sup> cDC2s was cell-intrinsic and could be rescued by conditional overexpression of the constitutively active NOTCH intracellular domain in CD11c-expressing cells. Therefore, TAOK3 controls the terminal differentiation of NOTCH2-dependent splenic cDC2s.
Medical subject headings
- Cell Differentiation
- Dendritic Cells
- Protein Kinases
- Receptor, Notch2
- Spleen